During the extraperitoneal growth of OCM, podoplanin-positive and α smooth muscle actin (αSMA)-positive cancer-associated fibroblasts (CAF) appears. In more advanced lesions, the boundary line of mesothelial cells disappears around the insertion areas of feeding vessels and then extraperitoneal and intraperitoneal stroma are integrated, enabling the OCM to invade the host stroma, being associated with CAF. In addition, tissue factors (TF) are strongly detected around these peritoneal implantation sites and their levels in ascites were higher than that in blood. These findings demonstrate the presence of neovascularization around fibrin net-anchored OCMs on the outer side of the intact peritoneal surface, suggesting a novel strategy for peritoneal invasion of ovarian cancer and TF-targeted intraperitoneal anti-cancer treatment. We observed and propose a novel strategy for peritoneal implantation of ovarian cancer. The strategy includes the preinvasive growth of fibrin-anchored cancer cells along with neovascularization on the outer side of the intact peritoneal surface.
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| INTRODUC TI ON
Peritoneal dissemination is one of the main routes of metastasis in ovarian cancer. More than 75% of patients with ovarian cancer are diagnosed with metastases at advanced stages throughout the pelvic and peritoneal cavities. [1] [2] [3] Intraperitoneal dissemination of epithelial ovarian cancer cells is considered to be initiated by the shedding of tumor cells from the primary site into peritoneal fluids. Then, these tumor cells form free-floating multicellular masses, an ovarian cancer cell masses (OCM), and serve as a vehicle for widespread dissemination in the peritoneal cavity. 4 OCMs effused from cystic fluid in ovarian cancer were also reported to contribute to intraperitoneal dissemination. 5, 6 During these processes, the process of disconnection of cell-to-cell interactions has been shown to play a significant role in cells leaving the primary site and metastasizing to a distant site. and MET, which are important mechanisms for cell attachment, disaggregation, and migration, regulating the invasion and metastasis of cancer, were also proposed to be involved in these processes.
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In contrast with this concept, preparing a specific paraffin-embedded block of peritoneal lesions, we recently observed unique histological features in which OCMs grow along with neovascularization on the outer side of the intact peritoneal surface (extraperitoneal space) in the absence of direct attachment to the peritoneal epithelial cells, and then invade the peritoneal stroma (intraperitoneal space). Consequently, here we propose a novel pathway that can achieve successful peritoneal implantation of OCM.
| MATERIAL S AND ME THODS

| Immunohistochemistry
Twenty patients with ovarian carcinoma and with peritoneal dissemination, who underwent primary debulking surgery or exploratory laparotomy at Kanazawa University Hospital, Japan, were recruited into this study. The study was approved by the ethical committee at Kanazawa University and preoperative informed consent was obtained from the patients. Peritoneal specimens were fixed in 10% formalin under widely spreading conditions and then cut to 5 mm in width, placed vertically in cassettes and embedded in paraffin, and sliced into 3-μm sections.
At sites where the "extraperitoneal growth of OCM" were observed, 10 serial sections were additionally made for further investigation. The immunohistochemical staining method was performed as reported previously. 11 Briefly, heat-induced epitope retrieval was performed by boil- for 30 s, and 72°C for 30 s, in accordance with a previous report.
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After amplification, the resulting PCR products were purified with a MinElute Gel Extraction Kit (Qiagen). The purified PCR products were sequenced and detected using a DNA sequencer (3730xl DNA Analyzer; Thermo Fisher Scientific).
| Statistical methods
Statistical analysis was performed using the Statistical Package for the Social Sciences software, version 23 for Windows (SPSS). Continuous variables were compared using the Mann-Whitney U test and Wilcoxon signed-rank test, and are presented as the median and interquartile range.
| RE SULTS
| New strategy for peritoneal implantation: neovascularization around fibrin net-anchored OCM on the outer side of the intact peritoneal surface
Twenty patients with ovarian carcinoma were recruited in this study. All showed deep invasion of cancer cells in the peritoneal stromal tissues.
Eleven had high-grade serous carcinoma, and the remaining patients had mucinous carcinoma (n = 1), low-grade serous carcinoma (n = 2), poorly differentiated adenocarcinoma (n = 3), adenocarcinoma (n = 1), and clear cell carcinoma (n = 2). Among 13 patients with serous carcinoma, in 6 (case #1-5,12. Table 1 Immunoreactive fibrinogen was detected on these fibrous tissues ( Figure 1G ), indicating that this structure was composed of fibrin networks, being consistent with previous reports. 13, 14 We also ob- At further advanced sites (Figure 3) , the boundary line of mesothelial cells widely disappeared and both peritoneal and OCM-surrounding stromal tissues were completely integrated together ( Figure 3A -C); this action can be confirmed by the presence of freely communicating CAF beyond the boundary ( Figure 3B ). In some regions, these integrated areas were fused together and invading OCMs were predominantly observed around the feeding vessels ( Figure 3D-F) .
This situation enables the OCM to invade the peritoneal stroma, being associated with CAF ( Figure 3G-I) . The high expression of TF was also observed around the OCM ( Figure 3C,I ).
| Identification of TF in ascitic fluid and peritoneal metastatic lesions
As TF was strongly expressed around the peritoneal dissemination site of cancer cells, we measured plasma and ascitic TF levels (n = 25 and n = 20, respectively) in patients with ovarian cancer (n = 33).
The median value of ascitic TF was significantly higher than that of plasma TF ( Figure 4A ). In 12 patients, we could obtain both plasma and ascitic samples and compare these, confirming that the TF level in ascites was higher than that in blood ( Figure 4B ). In 2 of these, the ascitic levels of TF decreased in accordance with the time course of chemotherapy ( Table 1) . In case #12, mRNA expression of TF was confirmed by RT-PCR both in primary and peritoneal metastatic regions (Table 1 and Figure 4C ).
| D ISCUSS I ON
In this study, we observed unique histological features of peritoneal invasion of OCMs in 6 of 13 patients with serous carcinoma, showing Figure 5D ).
To explain the above steps, we further suggested the following mechanisms. As the 1st step, OCMs induce leakage of fibrinogen on the surface of the peritoneal wall. Although we have no definite evidence for this step, previous studies have demonstrated that tumor cells in ascites can induce superficial microvascular congestion and hyperpermeability in the underlying stroma of the peritoneum, and fibrin deposition on the surface of peritoneal epithelial cells. 13, 14 Being consistent with these reports, we observed abundant dilated vessels with the accumulation of VEGF-A in the stroma under the intact mesothelial cell layer that faces the OCM. For the 2nd step, the fibrin-net structure traps the OCMs in peritoneal fluids, anchoring these to the peritoneal wall. As TF, which converts fibrinogen to fibrin, was clearly detected on the OCM-anchoring fibrin net (Figure 1H ), the fibrous network may be constructed from the exudated fibrinogen by TF. It should be noted that fibrin was reported to contribute to successful tumor implantation by allowing metastatic cells to provide requisite signals for adhesion to the peritoneal wall and neovascularization in the F I G U R E 4 The ascitic and plasma levels of transfer factor (TF) in patients with ovarian cancer. The plasma and ascitic TF levels (n = 25 and n = 20, respectively) were measured in patients (total n = 33) with ovarian cancer. A, The median value of ascitic TF was significantly higher than that of plasma TF. B, In 12 cases, we could obtain both plasma and ascitic samples. It was also confirmed that the TF level in ascites was higher than that in blood. C, RT-PCR was performed to confirm the presence of TF in the tissue of ovarian cancer (case #11). mRNA expression of TF was confirmed both in primary and peritoneal metastatic regions. Met, peritoneal metastasis; NC, negative control; PC, positive control (ovarian cancer cell line; SKOV3); Pri, primary lesion. *P < .001. **P = .001
Ascites Blood Step IV. The boundary layer of mesothelial cells disappears and both intraperitoneal host stromal tissues and extraperitoneal OCM-surrounding stromal tissues are integrated together, enabling the OCM to invade the host stroma, being accompanied by CAF underlying peritoneal stroma through local inflammation, promoting the production of ascites. 13, 14 As a novel finding, this study showed that these fibrin nets can offer a framework for the subsequent migration of CD31/CD34/VEGF-A-positive endothelial cells and podoplanin-positive fibroblasts. This process may be fundamentally based on tissue remodeling and repair mechanisms through coagulation systems. Surprisingly, these endothelial cells then constructed fine functional vessel networks, which contained circulating red blood cells, around OCM outside the intact mesothelial cell layer ( Figure 1M,N) .
For the 3rd step, vascular networks became established around OCM. In addition, fibroblasts around OCM enhance the expression of CAF markers, αSMA, and podoplanin. These stromal cells and OCM express SDF-1/CXCL12 ( Figure 2F ), which was reported to induce invasive activity in various cancer cells. [15] [16] [17] [18] Considering that the volume of OCMs was largely greater than those in the fibrous nets, the development of the blood supply may contribute to growing and activating OCM outside the intact mesothelial cell layer.
Around the insertion sites of feeding vessels, local inflammation was induced by the OCM or CAF, leading to disruption of the mesothelial cell barrier.
For the final step, the mesothelial cell layer disappeared, creating a wide area allowing direct interaction with the OCM-surrounding stroma and resident peritoneal stroma. In this stage, OCM invaded resident peritoneal stroma through the disrupted area that contained feeding vessels, being accompanied by CAF.
We hypothesized that the coagulation system is involved in the initial process of peritoneal implantation. To investigate this, immunoreactive TF was evaluated and found to be abundant in OCM ( Figures 1H, 2C, 3C,I ). Previous reports have suggested that cytokine-induced and/or chemokine-induced TF expression in tumor cells and tumor-connective tissues promotes neo-angiogenesis, invasion, and metastasis in ovarian cancer. 3, 19 Recently, Matsumura's group. [20] [21] [22] demonstrated that the systemic administration of selective anti-TF antibody conjugated with an anti-cancer drug was effective for growth inhibition of human pancreatic and gastric cancer cell lines using murine intravenous xenograft models without affecting coagulant activity. Importantly, this effect was also observed in xenograft experiments using a TF-low-expressing cancer cell line, suggesting the metastatic tumor-induced TF expression in adjacent stromal cells. 21 Conversely, intraperitoneal chemotherapy has been accepted as one of the effective strategies against ovarian cancers. 23 Consequently, considering high TF expression in ascites and around implanting OCM on the outer side of the peritoneal wall, the intraperitoneal administration of anti-TF antibody conjugated with an anti-cancer drug may become one of the prospective therapies against ovarian cancers.
The main limitation of this report is that the proposed strategy is fundamentally based on morphological findings in only 6 patients.
The lack of molecular experiments to support the expression of key factors and absence of in vitro or animal experiments to confirm the proposed strategy are also weak points. However, approximately half the total number of cases with serous carcinoma (6 in 13)
showed similar histological images of extraperitoneal growth along with the feeding vessels from noninvaded intraperitoneal stroma. 
